While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. Revenues are expected to be $31.19 million, down 13.5% from the year-ago quarter. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. The Zacks Earnings ESP compares the ...

Outset Medical, Inc. (OM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. Most Powerful Force Impacting Stock Prices The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressiv ...

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.55%. A quarter ago, it was expected that this company would post a loss of $0.61 per share when it actually produced a loss of $0.59, delivering a surprise of 3.28%.Over the last four quarters, the company has surpas ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdictio ...

Exhibit 99.1 Outset Medical Reports First Quarter 2024 Financial Results San Jose, CA – May 8, 2024 – Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2024. "With our recent 510(k) clearance for TabloCart with Prefiltration, 12 th consecutive quarter of gross margin expansion and strong sales pipeline growth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39513 Outset Medical, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-0514392 Washington, D.C. 20549 (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdi ...

0% Dropout during in-home period 99% ~10% Reported less cramping during treatment | --- | --- | |--------------------------------------------|-------| | | | | 61% | | | | | | Felt more relaxed during treatment | | | 48% | | | | | | Had fewer headaches after dialysis | | | 47% | | Commercial strategy Acute DRIVERS / BENEFITS New revenue stream Attractive contribution margin Discharge management solution Home | --- | --- | --- | --- | |------------------------------------|-------|-------|-------| | capitalize ...

Outset Medical, Inc. (NASDAQ:OM) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Jim Mazzola - Vice President, Investor Relations Leslie Trigg - Chair & Chief Executive Officer Nabeel Ahmed - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Rick Wise - Stifel Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer & Company Josh Jennings - TD Cowen Drew Ranieri - Morgan Stanley Operator Good day, and thank you for standing-by ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) Delaware 20-0514392 (State or other jurisdiction of incorporation or organization) 3052 Orchard Dr. San Jose, California 95134 (Address of principal executive offices) (Zip Code) For the quarterly period ended June 30, 2023 (I.R.S. Employer Identification No.) OR Registrant's telephone number, including area code: (669) 231-8200 ...